François Delhommeau

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

Chloé James, Valérie Ugo, Jean‐Pierre Le Couedic et al. · Nature · 2005 · 3.5K citations

Hematological Malignancy, Signal Transduction, Receptor Tyrosine Kinase +9

Mutation in <i>TET2</i> in Myeloid Cancers

François Delhommeau, Sabrina Dupont, Véronique Della Valle et al. · New England Journal of Medicine · 2009 · 1.7K citations · Full text

TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis

Cyril Quivoron, Lucile Couronné, Véronique Della Valle et al. · Cancer Cell · 2011 · 884 citations · Full text

Recurrent Event, Lymphoid Neoplasia, Lymphocyte Development +9

Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism

Thomas Farge, Estelle Saland, Fabienne de Toni et al. · Cancer Discovery · 2017 · 877 citations · Full text

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

Ayalew Tefferi, Animesh Pardanani, Ken‐Hong Lim et al. · Leukemia · 2009 · 418 citations · Full text

Hematological Malignancy, Polycythemia Vera, Bone Marrow Failure +10